|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | A61P 35/00 | (2006.01) |
| A61P 43/00 | (2006.01) | ||
| C07K 16/28 | (2006.01) | ||
| C07K 14/725 | (2006.01) |
| (11) | Number of the document | 3227339 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15865633.0 |
| Date of filing the European patent application | 2015-12-04 | |
| (97) | Date of publication of the European application | 2017-10-11 |
| (45) | Date of publication and mention of the grant of the patent | 2021-11-10 |
| (46) | Date of publication of the claims translation | 2022-01-10 |
| (86) | Number | PCT/US2015/064102 |
| Date | 2015-12-04 |
| (87) | Number | WO 2016/090312 |
| Date | 2016-06-09 |
| (30) | Number | Date | Country code |
| 201462088286 P | 2014-12-05 | US |
| (72) |
BRENTJENS, Renier J. , US
SMITH, Eric L. , US
LIU, Cheng , US
LIU, Hong , US
|
| (73) |
Memorial Sloan-Kettering Cancer Center ,
1275 York Avenue, New York, NY 10065,
US
Eureka Therapeutics, Inc. , 5858 Horton Street, Suite 362, Emeryville, CA 94608, US |
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Chimeriniai antigeno receptoriai, nukreipti į receptorių su prijungtu G baltymu ir jų naudojimo būdai |
| CHIMERIC ANTIGEN RECEPTORS TARGETING G-PROTEIN COUPLED RECEPTOR AND USES THEREOF |
| Payment date | Validity (years) | Amount | |
| 2023-11-10 | 9 | 208.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2024-12-04 |